ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antidepressants Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-25I109
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antidepressants Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Antidepressants Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-25I109
Report
December 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Astrazeneca plc
Eli Lilly and Company
Novartis
GlaxoSmithKline PLC
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals

Antidepressants Drugs Market Size

The global Antidepressants Drugs market is projected to grow from US$ 14890 million in 2024 to US$ 18090 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.

Antidepressants Drugs Market

Antidepressants Drugs Market

Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.
Market Analysis and Insights: Global Antidepressants Drugs Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Antidepressants Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antidepressants Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antidepressants Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antidepressants Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antidepressants Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antidepressants Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Antidepressants Drugs Market Report

Report Metric Details
Report Name Antidepressants Drugs Market
Accounted market size in 2024 US$ 14890 in million
Forecasted market size in 2030 US$ 18090 million
CAGR 3.3
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter, Janssen Pharmaceuticals, Lupin Pharmaceuticals, Luye Pharma, MSI Methylation Sciences, Naurex, SK Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Antidepressants Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antidepressants Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidepressants Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Antidepressants Drugs Market growing?

Ans: The Antidepressants Drugs Market witnessing a CAGR of 3.3 during the forecast period 2025-2030.

What is the Antidepressants Drugs Market size in 2030?

Ans: The Antidepressants Drugs Market size in 2030 will be US$ 18090 million.

Who are the main players in the Antidepressants Drugs Market report?

Ans: The main players in the Antidepressants Drugs Market are Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter, Janssen Pharmaceuticals, Lupin Pharmaceuticals, Luye Pharma, MSI Methylation Sciences, Naurex, SK Biopharmaceuticals

What are the Application segmentation covered in the Antidepressants Drugs Market report?

Ans: The Applications covered in the Antidepressants Drugs Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Antidepressants Drugs Market report?

Ans: The Types covered in the Antidepressants Drugs Market report are Tricyclic Antidepressants, Serotonin-norepinephrine Inhibitors, Atypical Antipsychotics, Selective Serotonin Reuptake Inhibitors, Benzodiazepines, Tetracyclic Antidepressants, Monoamine Oxidase Inhibitors, Others

Recommended Reports

Neuropsychiatric Drugs

Central Nervous System

Prescription Drug Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antidepressants Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Tricyclic Antidepressants
1.2.3 Serotonin-norepinephrine Inhibitors
1.2.4 Atypical Antipsychotics
1.2.5 Selective Serotonin Reuptake Inhibitors
1.2.6 Benzodiazepines
1.2.7 Tetracyclic Antidepressants
1.2.8 Monoamine Oxidase Inhibitors
1.2.9 Others
1.3 Market by Application
1.3.1 Global Antidepressants Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antidepressants Drugs Market Perspective (2019-2030)
2.2 Global Antidepressants Drugs Growth Trends by Region
2.2.1 Antidepressants Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antidepressants Drugs Historic Market Size by Region (2019-2024)
2.2.3 Antidepressants Drugs Forecasted Market Size by Region (2025-2030)
2.3 Antidepressants Drugs Market Dynamics
2.3.1 Antidepressants Drugs Industry Trends
2.3.2 Antidepressants Drugs Market Drivers
2.3.3 Antidepressants Drugs Market Challenges
2.3.4 Antidepressants Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antidepressants Drugs by Players
3.1.1 Global Antidepressants Drugs Revenue by Players (2019-2024)
3.1.2 Global Antidepressants Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Antidepressants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antidepressants Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Antidepressants Drugs Market Concentration Ratio
3.4.1 Global Antidepressants Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antidepressants Drugs Revenue in 2023
3.5 Global Key Players of Antidepressants Drugs Head office and Area Served
3.6 Global Key Players of Antidepressants Drugs, Product and Application
3.7 Global Key Players of Antidepressants Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antidepressants Drugs Breakdown Data by Type
4.1 Global Antidepressants Drugs Historic Market Size by Type (2019-2024)
4.2 Global Antidepressants Drugs Forecasted Market Size by Type (2025-2030)
5 Antidepressants Drugs Breakdown Data by Application
5.1 Global Antidepressants Drugs Historic Market Size by Application (2019-2024)
5.2 Global Antidepressants Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antidepressants Drugs Market Size (2019-2030)
6.2 North America Antidepressants Drugs Market Size by Type
6.2.1 North America Antidepressants Drugs Market Size by Type (2019-2024)
6.2.2 North America Antidepressants Drugs Market Size by Type (2025-2030)
6.2.3 North America Antidepressants Drugs Market Share by Type (2019-2030)
6.3 North America Antidepressants Drugs Market Size by Application
6.3.1 North America Antidepressants Drugs Market Size by Application (2019-2024)
6.3.2 North America Antidepressants Drugs Market Size by Application (2025-2030)
6.3.3 North America Antidepressants Drugs Market Share by Application (2019-2030)
6.4 North America Antidepressants Drugs Market Size by Country
6.4.1 North America Antidepressants Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Antidepressants Drugs Market Size by Country (2019-2024)
6.4.3 North America Antidepressants Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antidepressants Drugs Market Size (2019-2030)
7.2 Europe Antidepressants Drugs Market Size by Type
7.2.1 Europe Antidepressants Drugs Market Size by Type (2019-2024)
7.2.2 Europe Antidepressants Drugs Market Size by Type (2025-2030)
7.2.3 Europe Antidepressants Drugs Market Share by Type (2019-2030)
7.3 Europe Antidepressants Drugs Market Size by Application
7.3.1 Europe Antidepressants Drugs Market Size by Application (2019-2024)
7.3.2 Europe Antidepressants Drugs Market Size by Application (2025-2030)
7.3.3 Europe Antidepressants Drugs Market Share by Application (2019-2030)
7.4 Europe Antidepressants Drugs Market Size by Country
7.4.1 Europe Antidepressants Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Antidepressants Drugs Market Size by Country (2019-2024)
7.4.3 Europe Antidepressants Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antidepressants Drugs Market Size (2019-2030)
8.2 China Antidepressants Drugs Market Size by Type
8.2.1 China Antidepressants Drugs Market Size by Type (2019-2024)
8.2.2 China Antidepressants Drugs Market Size by Type (2025-2030)
8.2.3 China Antidepressants Drugs Market Share by Type (2019-2030)
8.3 China Antidepressants Drugs Market Size by Application
8.3.1 China Antidepressants Drugs Market Size by Application (2019-2024)
8.3.2 China Antidepressants Drugs Market Size by Application (2025-2030)
8.3.3 China Antidepressants Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Antidepressants Drugs Market Size (2019-2030)
9.2 Asia Antidepressants Drugs Market Size by Type
9.2.1 Asia Antidepressants Drugs Market Size by Type (2019-2024)
9.2.2 Asia Antidepressants Drugs Market Size by Type (2025-2030)
9.2.3 Asia Antidepressants Drugs Market Share by Type (2019-2030)
9.3 Asia Antidepressants Drugs Market Size by Application
9.3.1 Asia Antidepressants Drugs Market Size by Application (2019-2024)
9.3.2 Asia Antidepressants Drugs Market Size by Application (2025-2030)
9.3.3 Asia Antidepressants Drugs Market Share by Application (2019-2030)
9.4 Asia Antidepressants Drugs Market Size by Region
9.4.1 Asia Antidepressants Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Antidepressants Drugs Market Size by Region (2019-2024)
9.4.3 Asia Antidepressants Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antidepressants Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Antidepressants Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Antidepressants Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antidepressants Drugs Introduction
11.1.4 Pfizer Revenue in Antidepressants Drugs Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Antidepressants Drugs Introduction
11.2.4 AstraZeneca Revenue in Antidepressants Drugs Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Antidepressants Drugs Introduction
11.3.4 Eli Lilly and Company Revenue in Antidepressants Drugs Business (2019-2024)
11.3.5 Eli Lilly and Company Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Antidepressants Drugs Introduction
11.4.4 Novartis Revenue in Antidepressants Drugs Business (2019-2024)
11.4.5 Novartis Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antidepressants Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Antidepressants Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Details
11.6.2 Otsuka Pharmaceutical Business Overview
11.6.3 Otsuka Pharmaceutical Antidepressants Drugs Introduction
11.6.4 Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2019-2024)
11.6.5 Otsuka Pharmaceutical Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Antidepressants Drugs Introduction
11.7.4 Abbott Laboratories Revenue in Antidepressants Drugs Business (2019-2024)
11.7.5 Abbott Laboratories Recent Developments
11.8 Gedeon Richter
11.8.1 Gedeon Richter Company Details
11.8.2 Gedeon Richter Business Overview
11.8.3 Gedeon Richter Antidepressants Drugs Introduction
11.8.4 Gedeon Richter Revenue in Antidepressants Drugs Business (2019-2024)
11.8.5 Gedeon Richter Recent Developments
11.9 Janssen Pharmaceuticals
11.9.1 Janssen Pharmaceuticals Company Details
11.9.2 Janssen Pharmaceuticals Business Overview
11.9.3 Janssen Pharmaceuticals Antidepressants Drugs Introduction
11.9.4 Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2019-2024)
11.9.5 Janssen Pharmaceuticals Recent Developments
11.10 Lupin Pharmaceuticals
11.10.1 Lupin Pharmaceuticals Company Details
11.10.2 Lupin Pharmaceuticals Business Overview
11.10.3 Lupin Pharmaceuticals Antidepressants Drugs Introduction
11.10.4 Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2019-2024)
11.10.5 Lupin Pharmaceuticals Recent Developments
11.11 Luye Pharma
11.11.1 Luye Pharma Company Details
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Antidepressants Drugs Introduction
11.11.4 Luye Pharma Revenue in Antidepressants Drugs Business (2019-2024)
11.11.5 Luye Pharma Recent Developments
11.12 MSI Methylation Sciences
11.12.1 MSI Methylation Sciences Company Details
11.12.2 MSI Methylation Sciences Business Overview
11.12.3 MSI Methylation Sciences Antidepressants Drugs Introduction
11.12.4 MSI Methylation Sciences Revenue in Antidepressants Drugs Business (2019-2024)
11.12.5 MSI Methylation Sciences Recent Developments
11.13 Naurex
11.13.1 Naurex Company Details
11.13.2 Naurex Business Overview
11.13.3 Naurex Antidepressants Drugs Introduction
11.13.4 Naurex Revenue in Antidepressants Drugs Business (2019-2024)
11.13.5 Naurex Recent Developments
11.14 SK Biopharmaceuticals
11.14.1 SK Biopharmaceuticals Company Details
11.14.2 SK Biopharmaceuticals Business Overview
11.14.3 SK Biopharmaceuticals Antidepressants Drugs Introduction
11.14.4 SK Biopharmaceuticals Revenue in Antidepressants Drugs Business (2019-2024)
11.14.5 SK Biopharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Pfizer Inc
Astrazeneca plc
Eli Lilly and Company
Novartis
GlaxoSmithKline PLC
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals
List of Tables
    Table 1. Global Antidepressants Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Tricyclic Antidepressants
    Table 3. Key Players of Serotonin-norepinephrine Inhibitors
    Table 4. Key Players of Atypical Antipsychotics
    Table 5. Key Players of Selective Serotonin Reuptake Inhibitors
    Table 6. Key Players of Benzodiazepines
    Table 7. Key Players of Tetracyclic Antidepressants
    Table 8. Key Players of Monoamine Oxidase Inhibitors
    Table 9. Key Players of Others
    Table 10. Global Antidepressants Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 11. Global Antidepressants Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Antidepressants Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Antidepressants Drugs Market Share by Region (2019-2024)
    Table 14. Global Antidepressants Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Antidepressants Drugs Market Share by Region (2025-2030)
    Table 16. Antidepressants Drugs Market Trends
    Table 17. Antidepressants Drugs Market Drivers
    Table 18. Antidepressants Drugs Market Challenges
    Table 19. Antidepressants Drugs Market Restraints
    Table 20. Global Antidepressants Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Antidepressants Drugs Revenue Share by Players (2019-2024)
    Table 22. Global Top Antidepressants Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidepressants Drugs as of 2023)
    Table 23. Global Antidepressants Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 24. Global 5 Largest Players Market Share by Antidepressants Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Global Key Players of Antidepressants Drugs, Headquarters and Area Served
    Table 26. Global Key Players of Antidepressants Drugs, Product and Application
    Table 27. Global Key Players of Antidepressants Drugs, Product and Application
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Antidepressants Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Antidepressants Drugs Revenue Market Share by Type (2019-2024)
    Table 31. Global Antidepressants Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Antidepressants Drugs Revenue Market Share by Type (2025-2030)
    Table 33. Global Antidepressants Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Antidepressants Drugs Revenue Share by Application (2019-2024)
    Table 35. Global Antidepressants Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Antidepressants Drugs Revenue Share by Application (2025-2030)
    Table 37. North America Antidepressants Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 38. North America Antidepressants Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 39. North America Antidepressants Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 40. North America Antidepressants Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 41. North America Antidepressants Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. North America Antidepressants Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 43. North America Antidepressants Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Europe Antidepressants Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 45. Europe Antidepressants Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 46. Europe Antidepressants Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 47. Europe Antidepressants Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 48. Europe Antidepressants Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Europe Antidepressants Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Europe Antidepressants Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 51. China Antidepressants Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 52. China Antidepressants Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 53. China Antidepressants Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 54. China Antidepressants Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Antidepressants Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 56. Asia Antidepressants Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 57. Asia Antidepressants Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 58. Asia Antidepressants Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 59. Asia Antidepressants Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 60. Asia Antidepressants Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 61. Asia Antidepressants Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Antidepressants Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 67. Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 68. Middle East, Africa, and Latin America Antidepressants Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 69. Pfizer Company Details
    Table 70. Pfizer Business Overview
    Table 71. Pfizer Antidepressants Drugs Product
    Table 72. Pfizer Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 73. Pfizer Recent Developments
    Table 74. AstraZeneca Company Details
    Table 75. AstraZeneca Business Overview
    Table 76. AstraZeneca Antidepressants Drugs Product
    Table 77. AstraZeneca Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 78. AstraZeneca Recent Developments
    Table 79. Eli Lilly and Company Company Details
    Table 80. Eli Lilly and Company Business Overview
    Table 81. Eli Lilly and Company Antidepressants Drugs Product
    Table 82. Eli Lilly and Company Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 83. Eli Lilly and Company Recent Developments
    Table 84. Novartis Company Details
    Table 85. Novartis Business Overview
    Table 86. Novartis Antidepressants Drugs Product
    Table 87. Novartis Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 88. Novartis Recent Developments
    Table 89. GlaxoSmithKline Company Details
    Table 90. GlaxoSmithKline Business Overview
    Table 91. GlaxoSmithKline Antidepressants Drugs Product
    Table 92. GlaxoSmithKline Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 93. GlaxoSmithKline Recent Developments
    Table 94. Otsuka Pharmaceutical Company Details
    Table 95. Otsuka Pharmaceutical Business Overview
    Table 96. Otsuka Pharmaceutical Antidepressants Drugs Product
    Table 97. Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 98. Otsuka Pharmaceutical Recent Developments
    Table 99. Abbott Laboratories Company Details
    Table 100. Abbott Laboratories Business Overview
    Table 101. Abbott Laboratories Antidepressants Drugs Product
    Table 102. Abbott Laboratories Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 103. Abbott Laboratories Recent Developments
    Table 104. Gedeon Richter Company Details
    Table 105. Gedeon Richter Business Overview
    Table 106. Gedeon Richter Antidepressants Drugs Product
    Table 107. Gedeon Richter Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 108. Gedeon Richter Recent Developments
    Table 109. Janssen Pharmaceuticals Company Details
    Table 110. Janssen Pharmaceuticals Business Overview
    Table 111. Janssen Pharmaceuticals Antidepressants Drugs Product
    Table 112. Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 113. Janssen Pharmaceuticals Recent Developments
    Table 114. Lupin Pharmaceuticals Company Details
    Table 115. Lupin Pharmaceuticals Business Overview
    Table 116. Lupin Pharmaceuticals Antidepressants Drugs Product
    Table 117. Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 118. Lupin Pharmaceuticals Recent Developments
    Table 119. Luye Pharma Company Details
    Table 120. Luye Pharma Business Overview
    Table 121. Luye Pharma Antidepressants Drugs Product
    Table 122. Luye Pharma Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 123. Luye Pharma Recent Developments
    Table 124. MSI Methylation Sciences Company Details
    Table 125. MSI Methylation Sciences Business Overview
    Table 126. MSI Methylation Sciences Antidepressants Drugs Product
    Table 127. MSI Methylation Sciences Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 128. MSI Methylation Sciences Recent Developments
    Table 129. Naurex Company Details
    Table 130. Naurex Business Overview
    Table 131. Naurex Antidepressants Drugs Product
    Table 132. Naurex Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 133. Naurex Recent Developments
    Table 134. SK Biopharmaceuticals Company Details
    Table 135. SK Biopharmaceuticals Business Overview
    Table 136. SK Biopharmaceuticals Antidepressants Drugs Product
    Table 137. SK Biopharmaceuticals Revenue in Antidepressants Drugs Business (2019-2024) & (US$ Million)
    Table 138. SK Biopharmaceuticals Recent Developments
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antidepressants Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Antidepressants Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Tricyclic Antidepressants Features
    Figure 4. Serotonin-norepinephrine Inhibitors Features
    Figure 5. Atypical Antipsychotics Features
    Figure 6. Selective Serotonin Reuptake Inhibitors Features
    Figure 7. Benzodiazepines Features
    Figure 8. Tetracyclic Antidepressants Features
    Figure 9. Monoamine Oxidase Inhibitors Features
    Figure 10. Others Features
    Figure 11. Global Antidepressants Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Antidepressants Drugs Market Share by Application: 2023 VS 2030
    Figure 13. Hospitals Case Studies
    Figure 14. Clinics Case Studies
    Figure 15. Others Case Studies
    Figure 16. Antidepressants Drugs Report Years Considered
    Figure 17. Global Antidepressants Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Antidepressants Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Antidepressants Drugs Market Share by Region: 2023 VS 2030
    Figure 20. Global Antidepressants Drugs Market Share by Players in 2023
    Figure 21. Global Top Antidepressants Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidepressants Drugs as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Antidepressants Drugs Revenue in 2023
    Figure 23. North America Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Antidepressants Drugs Market Share by Type (2019-2030)
    Figure 25. North America Antidepressants Drugs Market Share by Application (2019-2030)
    Figure 26. North America Antidepressants Drugs Market Share by Country (2019-2030)
    Figure 27. United States Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Antidepressants Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Antidepressants Drugs Market Share by Type (2019-2030)
    Figure 31. Europe Antidepressants Drugs Market Share by Application (2019-2030)
    Figure 32. Europe Antidepressants Drugs Market Share by Country (2019-2030)
    Figure 33. Germany Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Antidepressants Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Antidepressants Drugs Market Share by Type (2019-2030)
    Figure 41. China Antidepressants Drugs Market Share by Application (2019-2030)
    Figure 42. Asia Antidepressants Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Antidepressants Drugs Market Share by Type (2019-2030)
    Figure 44. Asia Antidepressants Drugs Market Share by Application (2019-2030)
    Figure 45. Asia Antidepressants Drugs Market Share by Region (2019-2030)
    Figure 46. Japan Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Antidepressants Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Antidepressants Drugs Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Antidepressants Drugs Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Antidepressants Drugs Market Share by Country (2019-2030)
    Figure 56. Brazil Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Antidepressants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Pfizer Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 63. AstraZeneca Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 64. Eli Lilly and Company Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 66. GlaxoSmithKline Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 67. Otsuka Pharmaceutical Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 68. Abbott Laboratories Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 69. Gedeon Richter Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 70. Janssen Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 71. Lupin Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 72. Luye Pharma Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 73. MSI Methylation Sciences Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 74. Naurex Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 75. SK Biopharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Anti depressant Drugs Market
Anti Depression Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Selective Serotonin Reuptake Inhibitors SSRIs Market Insights Forecast to 2030
Global Sertraline Market Insights Forecast to 2030
Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Depression Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Antidepressant Medication Market Research Report 2025
Global Insomnia Treatment Drugs Market Insights Forecast to 2030
Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Major Depressive Disorder Drug Market Research Report 2025
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psychiatric and Nervous Drugs Market Research Report 2025
Global Mental Health Medications Market Research Report 2025
Anti Anxiety Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anxiety Disorders And Depression Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ADHD Medications Market Insights Forecast to 2030
Anxiety and Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cold Treatment Drug Market Insights Forecast to 2030
Global Anxiety Disorders Treatment Market Insights Forecast to 2030
Depression Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions